ArticleLa Radiologia medica2019
Transarterial embolization of peripheral high-flow arteriovenous malformation with ethylene vinyl alcohol copolymer (Onyx
Article in La Radiologia medica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice.Cardiovascular and interventional radiology · 2026Article
- Primer on Embolic Agents and Sclerosants for the Treatment of Vascular Malformations.Seminars in interventional radiology · 2024Review
- High-Flow Arteriovenous Malformations: Treatment Using a Venous Approach.Seminars in interventional radiology · 2024Review
- Contemporary management of extracranial vascular malformations.Pediatric radiology · 2023Review
- Liquid Embolic Agents for Endovascular Embolization: A Review.Gels (Basel, Switzerland) · 2023Review
- The trend of percutaneous and open surgical procedures for peripheral arteriovenous malformations in the National Health Service England.Annals of the Royal College of Surgeons of England · 2022Article
- Surgical management of auricular arteriovenous malformations: A literature review.Laryngoscope investigative otolaryngology · 2022Review
- Review
- Liquid Embolization of Peripheral Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer in Neonates and Infants.Cardiovascular therapeutics · 2022Article
- Post-Traumatic Intraparenchymal Renal Hemorrhages: Correlation between CT and DSA Vascular Findings for Superselective Embolization Procedures.Diagnostics (Basel, Switzerland) · 2021Article
- Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHILLa Radiologia medica · 2021Article
- Interventional radiology in gynecology and obstetric practice: Safety issues.Seminars in ultrasound, CT, and MR · 2021Review
- Intraoral Excision and Preoperative Embolization of a Von Hippel-Lindau Disease-associated Facial Arteriovenous Malformation.Plastic and reconstructive surgery. Global open · 2020Article
- Early middle meningeal artery embolization for small acute epidural hematomas: a clinical study from a single center.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHigh-flow arteriovenous malformations (AVMs) are complex vascular lesions for which transcatheter embolization is considered as first-choice treatment nowadays. Multiple embolizing agents have been described, and among them, Onyx MATERIALS AND
methodsRetrospective analysis was conducted on patients affected by high-flow AVM and treated electively by transarterial embolization with Onyx
resultsSixteen patients have been included, totally 38 embolizing procedures. Additional embolizing agents were required in 5 patients. Technical success was obtained in 11 patients; at 30-day follow-up, 15 patients showed improvements in symptoms, even those with incomplete embolization; however, after almost 1 year from treatment accomplishment, 7 patients showed relapse of symptoms and presented radiological signs of AVM recurrence. No clinically relevant complications occurred.
conclusionsIn this series, in accordance with previous but limited published data, Onyx
Indexed as
Identifiers
30368719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.